BiotechTube
Home/Royalty Pharma/Pablo Legorreta
PL

Pablo Legorreta

Founder and Chief Executive Officer

Royalty Pharma

Therapeutic Areas

OncologyImmunologyNeurologyRespiratoryRare DiseasesInfectious Disease

Royalty Pharma Pipeline

DrugIndicationPhase
HumiraAutoimmune disordersCommercial
ImbruvicaBlood cancersCommercial
SpinrazaSpinal muscular atrophyCommercial
CabometyxRenal cell carcinomaCommercial
TrelegyCOPD/AsthmaCommercial
TrodelvyBreast cancerCommercial
EvrysdiSpinal muscular atrophyCommercial
OrladeyoHereditary angioedemaCommercial

Leadership Team at Royalty Pharma

TC
Terrance Coyne
Chief Financial Officer
GL
George Lloyd
Chief Investment Officer
JF
James F. Martin
General Counsel and Chief Compliance Officer
CH
Christopher Hite
Chief Business Officer
MU
Marshall Urist
Head of Research
View full Royalty Pharma profile